ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

UNCY Unicycive Therapeutics Inc

1.12
0.00 (0.00%)
プレマーケット
最終更新日: 17:00:00
15分遅延
名称 銘柄コード 市場 種別
Unicycive Therapeutics Inc UNCY NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 1.12 17:00:00
始値 安値 高値 終値 前日終値
1.12
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1020:03GLOBEUnicycive Therapeutics to Present at the Noble Capital..
2024/3/2905:15GLOBEUnicycive Therapeutics Announces Full Year 2023 Financial..
2024/3/2520:03GLOBEUnicycive Therapeutics to be Featured in Multiple..
2024/3/1420:03GLOBEUnicycive Announces $50 Million Private Placement
2024/3/1320:03GLOBEUnicycive Therapeutics Delivers Both an Oral and Poster..
2024/3/0806:12GLOBEUnicycive Therapeutics Completes Enrollment in Pivotal..
2024/3/0421:03GLOBEUnicycive Therapeutics Announces Orphan Drug Designation..
2024/2/2206:06EDGAR2Form 8-K - Current report
2024/2/1421:03GLOBEUnicycive Therapeutics to Present Two Posters on..
2024/1/2921:03GLOBEUnicycive Therapeutics Announces Both an Oral and Poster..
2024/1/2321:03GLOBEUnicycive Therapeutics Issues Shareholder Letter to..
2024/1/2306:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/1821:03GLOBEUnicycive Therapeutics Announces Enrollment of First Patient..
2023/12/0906:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/11/2921:03GLOBEUnicycive Therapeutics to Participate in Two Investor..
2023/11/1506:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1506:15GLOBEUnicycive Announces Third Quarter 2023 Financial Results and..
2023/10/2400:12EDGAR2Form 8-K - Current report
2023/10/2320:03GLOBEUnicycive Therapeutics Reaches Alignment with the FDA on..
2023/9/2605:05EDGAR2Form 8-K - Current report
2023/9/0805:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0805:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/0622:16EDGAR2Form 8-K - Current report
2023/9/0620:03GLOBEUnicycive Therapeutics Strengthens Board of Directors with..
2023/9/0105:16EDGAR2Form 8-K - Current report
2023/8/3105:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3105:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3105:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2920:03GLOBEUnicycive Therapeutics Featured on Nasdaq Amplify Issuer..
2023/8/1506:36GLOBEUnicycive Announces Second Quarter 2023 Financial Results..
2023/8/1506:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0105:15EDGAR2Form 8-K - Current report
2023/7/2619:05EDGAR2Form 8-K - Current report
2023/7/2020:03GLOBEUnicycive Therapeutics to Participate in the H.C. Wainwright..
2023/7/1820:03GLOBEUnicycive Therapeutics Announces Publication of Positive..
2023/7/1505:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/7/1408:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1407:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/3006:04GLOBEUnicycive Therapeutics Provides Regulatory Update on..
2023/6/1620:38GLOBEUnicycive to Participate in the Healthcare Virtual..
2023/5/1621:29GLOBEUnicycive Announces First Quarter 2023 Financial Results and..

最近閲覧した銘柄

Delayed Upgrade Clock